Efficacy and Mechanisms of Action of rmB7.2-Ig as an Antitumor Agent in Combination with Adriamycin and Cytoxan Chemotherapy

Author:

Zhou Huanfang,Sequeira Manuel,Goad Mary E.P.,Erickson Jamie,Wong Anthony,Clark Ed,Dunussi-Joannopoulos Kyriaki,Li Ronald C.,Friedrich Stuart,Hayes Lori L.,Wolf Stanley F.

Publisher

Elsevier BV

Subject

Immunology,Immunology and Allergy

Reference17 articles.

1. Potent activity of soluble B7-IgG fusion proteins in therapy of established tumors and as vaccine adjuvant;Sturmhoefel;Cancer Res.,1999

2. The combination of chemotherapy and systemic immunotherapy with soluble B7-IgG leads to cure of murine leukemia and lymphoma and demonstration of tumor-specific memory responses;Runyon;Blood,2001

3. Antitumor immunity elicited by tumor cells transfected with B7-2, a second ligand for CD28/CTLA-4 costimulatory molecules;Yang;J. Immunol.,1995

4. CD28/B7 costimulation: A review;Greenfield;Crit. Rev.,1998

5. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors;Townsend;Cancer Res.,1994

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3